PHENYLBUTAZONE IN THE TREATMENT OF RHEUMATIC DISEASES. A SURVEY AND CLINICAL REPORT.

[1]  L. R. Kimsey.  Treatment of superficial thrombophlebitis with phenylbutazone. , 1960, Journal of the American Medical Association.

[2]  T. Jávor,et al.  Experimental phenylbutzone ulcer in dogs. , 1959, Gastroenterology.

[3]  C. W. Wilson,et al.  Phenylbutazone and gastric ulceration in the guinea pig. , 1959, Gastroenterology.

[4]  C. W. Wilson,et al.  The changes produced by phenylbutazone in the gastric secretion of the guinea pig. , 1959, Gastroenterology.

[5]  K. Sigg.  [Butazolidin & compression therapy of thrombosis]. , 1959, Praxis.

[6]  S. Björkman.  Phenylbutazone in the treatment of temporal arteritis. , 1958 .

[7]  Mason Rm,et al.  The present status of phenylbutazone therapy in rheumatic disease. , 1958 .

[8]  G. Wilhelmi.  [Combined use of butazolidin (phenylbutazone) and some corticosteroids in experimental inflammations]. , 1958, Schweizerische medizinische Wochenschrift.

[9]  J. Duthie,et al.  Response of megaloblastic anaemia of prednisolone. , 1957, Lancet.

[10]  N. Howard.  The value of irradiation in ankylosing spondylitis. , 1957, The British journal of radiology.

[11]  C. J. Smyth,et al.  Phenylbutazone in rheumatoid arthritis. , 1957, Journal of chronic diseases.

[12]  K. Muller.  [Prevention of complications during therapy of thromboses and myocardial infarct with anticoagulants (heparin, coumarin) by successful administration of butazolidin]. , 1957, Schweizerische medizinische Wochenschrift.

[13]  W. Naugler,et al.  Phenylbutazone; effects of its administration for prolonged periods. , 1957, The New England journal of medicine.

[14]  Mcmahon Mf.  Clinical effects of Butazolidin. , 1957 .

[15]  P. Kaufmann.  [Comparison between anticoagulants & butazolidin in prevention of thromboembolism]. , 1957, Schweizerische medizinische Wochenschrift.

[16]  J. Binswanger,et al.  [Attempted method of preventing thromboembolism without anticoagulants]. , 1957, Schweizerische medizinische Wochenschrift.

[17]  H. Bloch,et al.  [The question of postoperative thromboembolism prevention by butazolidin]. , 1957, Schweizerische medizinische Wochenschrift.

[18]  W. Baerlocher.  [Butazolidin prevention of postoperative thromboembolism with special consideration of urological cases]. , 1957, Schweizerische medizinische Wochenschrift.

[19]  S. Rageth,et al.  [Butazolidin as an additional factor in prevention of thromboembolism]. , 1957, Schweizerische medizinische Wochenschrift.

[20]  H. Triebold,et al.  [Prevention of postoperative and postpartal complications with butazolidin]. , 1957, Schweizerische medizinische Wochenschrift.

[21]  O. Lovgren,et al.  An acid-soluble phosphorus-containing fraction in blood and synovia from rheumatoid arthritis cases. , 1957, Acta rheumatologica Scandinavica.

[22]  C. Smyth,et al.  Oral phenylbutazone in the treatment of acute gouty arthritis. , 1956, The American journal of medicine.

[23]  W. Barczyk,et al.  [Review of 4 years of irgapyrin and butazolidine therapy of internal diseases]. , 1956, Medizinische Klinik.

[24]  C. Steer.  PHENYLBUTAZONE IN THE TREATMENT OF PROLAPSED INTERVERTEBRAL DISC , 1956 .

[25]  B. Brodie,et al.  Effect of a phenylbutazone analog (4-[phenylthioethyl]-1, 2-diphenyl 3, 5-pyrazolidinedione) on urate clearance and other discrete renal functions in gouty subjects; evaluation as uricosuric agent. , 1956, The Journal of clinical investigation.

[26]  Z. Cope.  Influence of the Society of Apothecaries upon Medical Education* , 1956, British medical journal.

[27]  E. McCormick.  Butazolidin in the treatment of non-articular rheumatic disorders. , 1956, Acta rheumatologica Scandinavica.

[28]  W. Naugler,et al.  Some observations on 520 gouty patients. , 1955, Journal of chronic diseases.

[29]  H. Hartig.  [Butazolidine in infectious mononucleosis]. , 1955, Medizinische Klinik.

[30]  I. Stein,et al.  Further Observations on the Treatment of Superficial Thrombophlebitis with Phenylbutazone (Butazolidin) , 1955, Circulation.

[31]  Joseph B. Kiesnee,et al.  Phenylbutazone (butazolidin); effect on basal gastric secretion and the production of gastroduodenal ulcerations in dogs. , 1955 .

[32]  J. Kirsner,et al.  Phenylbutazone (butazolidin); studies on the stimulation of gastric secretion and the formation of peptic ulcer in man. , 1955, Gastroenterology.

[33]  B. Bloom,et al.  Anuria following phenylbutazone therapy. , 1955, The New England journal of medicine.

[34]  W. P. Holbrook.  Cortisone, ACTH and phenylbutazone in long-term therapy of rheumatoid arthritis. , 1955, The Medical clinics of North America.

[35]  G. Edström.  Rheumatic Fever, its Symptoms, Prevention and Treatment , 1955 .

[36]  A. Larcan,et al.  [The place of phenylbutazone in the treatment of Bouillaud's disease]. , 1954, La Presse medicale.

[37]  V. Wynn.  Electrolyte disturbances associated with failure to metabolise glucose during hypothermia. , 1954, Lancet.

[38]  J. F. Rinehart,et al.  Hepatitis following the ingestion of phenylbutazone. , 1954, Journal of the American Medical Association.

[39]  P. Imhof,et al.  [The problem of butazolidine dosage]. , 1954, Schweizerische medizinische Wochenschrift.

[40]  O. A. Rose,et al.  Treatment of superficial thrombophlebitis with phenylbutazone (butazolidin). , 1954, A.M.A. archives of internal medicine.

[41]  P. Forsham,et al.  Effects of phenylbutazone in gout. , 1954, The New England journal of medicine.

[42]  S. Steel,et al.  Stevens—Johnson Syndrome and Granulocytopenia after Phenylbutazone , 1954, British medical journal.

[43]  A. Ferguson.  POLIOMYELITIS IN CHILDREN'S WARDS , 1954 .

[44]  O. Steinbrocker,et al.  Butazolidin in the treatment of gout with a comparison with other agents. , 1954, The Medical clinics of North America.

[45]  S. De seze,et al.  [Injectable phenylbutazone in rheumatology]. , 1954, La Presse medicale.

[46]  B. Brodie,et al.  Observations on the antirheumatic and physiologic effects of phenylbutazone (butazolidin) and some comparisons with cortisone. , 1954, The American journal of medicine.

[47]  W. Naugler,et al.  Phenylbutazone (butazolidin) in gout. , 1954, The American journal of medicine.

[48]  W. Zinn.  [Butazolidin in arthroses]. , 1954, Schweizerische medizinische Wochenschrift.

[49]  O. Gsell,et al.  [Combined cortisone and butazolidin therapy of chronic polyarthritis]. , 1953, Schweizerische medizinische Wochenschrift.

[50]  A. Gutman,et al.  Effect of phenylbutazone (3,5 dioxo-1,2-diphenyl-4-n-butylpyrazolidine) on renal clearance of urate and other discrete renal functions in gouty subjects. , 1953, The Journal of clinical investigation.

[51]  W. Naugler,et al.  Phenylbutazone; further clinical evaluation. , 1953, A.M.A. archives of internal medicine.

[52]  H. C. Fishman,et al.  Exfoliative dermatitis following ingestion of phenylbutazone (butazolidin). , 1953, Journal of the American Medical Association.

[53]  M. King.  Effect of Phenylbutazone (Butazolidin) on Renal Excretion of P-Aminohippurate and Thiosulfate in the Dog.∗ , 1953, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[54]  M. Thompson,et al.  Treatment of rheumatoid arthritis with phenylbutazone. , 1953, Lancet.

[55]  J. Nassim,et al.  Toxic Effects of Phenylbutazone , 1953, British medical journal.

[56]  J. C. Leonard.  Toxic Effects of Phenylbutazone , 1953, British medical journal.

[57]  R. Evans,et al.  Toxic effects of phenylbutazone. , 1953, Lancet.

[58]  J. Benstead.  Deaths of Two Patients Treated by Phenylbutazone , 1953, British medical journal.

[59]  P. Williams,et al.  Effect of butazolidine on the excretion of water and electrolytes. , 1953, Lancet.

[60]  R. Freyberg,et al.  Clinical Studies of Phenylbutazone (Butazolidin) and Butapyrin (Irgapyrin) in Rheumatoid Arthritis, Rheumatoid Spondylitis, and Gout * , 1953, Annals of the rheumatic diseases.

[61]  Von Rechenberg Hk.  [Butazolidine in therapy of rheumatic diseases; clinical tests with 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine-sodium, a new pyrazol derivative]. , 1953 .

[62]  R. Charet,et al.  UNUSUAL REACTION FOLLOWING USE OF PHENYLBUTAZONE (BUTAZOLIDIN®): REPORT OF A CASE , 1953 .

[63]  W. Bélart.  [Butazolidine as antirheumatic and its comparison with irgapyrin]. , 1953, Deutsche medizinische Wochenschrift.

[64]  R. Solomon.  Benefits and Dangers of Butazolidin , 1953 .

[65]  C. Hirson,et al.  Observations on Use of “Butazolidin” in Arthritis , 1952, British medical journal.

[66]  Freyberg Rh,et al.  Studies of butazolidin and butapyrin in patients with rheumatic diseases. , 1952 .

[67]  A. Gutman,et al.  Current principles of management in gout. , 1952, The American journal of medicine.

[68]  L. W. Granirer.  UNTOWARD EFFECTS OF PHENYLBUTAZONE (BUTAZOLIDIN , 1952 .

[69]  O. Steinbrocker,et al.  Phenylbutazone therapy of arthritis and other painful musculoskeletal disorders. , 1952, Journal of the American Medical Association.

[70]  W. P. Holbrook,et al.  Benefits and toxicity of phenylbutazone (butazolidin) in rheumatoid arthritis. , 1952, Journal of the American Medical Association.

[71]  R. Schaffarzick,et al.  Phenylbutazone (butazolidin) in rheumatoid arthritis and gout. , 1952, Journal of the American Medical Association.